Transaction value is based on the SEC Form 4 weighted average purchase price ($10.15), while post-transaction value is calculated using the market close price on October 23, 2025. The 477,401 shares ...

Tango Therapeutics Inc (TNGX) has reached a new 52-week high, with its stock price climbing to $17.64. This milestone marks a significant achievement for the company, reflecting a robust performance ...

Tango Therapeutics Inc (TNGX) reached a significant milestone as its stock price hit a 52-week high of 9.7 USD. This achievement reflects a remarkable 1-year change of 138.27%, underscoring the ...

Tango Therapeutics Inc. has reached a significant milestone, with its stock hitting an all-time high of $27.16. This achievement underscores a remarkable year for the company, as its stock has surged ...

Tango Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of novel cancer therapies using synthetic lethality. The company has a pipeline ...